Ownership history in RENAISSANCE TECHNOLOGIES LLC · 15 quarters on record
This page tracks every 13F SEC filing in which RENAISSANCE TECHNOLOGIES LLC reported a position in ACRIVON THERAPEUTICS INC (ACRV). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 634,169 | +10,769 | +1.7% | 0.00% | $1.5M | $2.41 |
| 2025 Q3 | ADDED | 623,400 | +114,105 | +22.4% | 0.00% | $1.1M | $1.81 |
| 2025 Q2 | ADDED | 509,295 | +457,195 | +877.5% | 0.00% | $606K | $1.19 |
| 2025 Q1 | ADDED | 52,100 | +2,700 | +5.5% | 0.00% | $106K | $2.03 |
| 2024 Q4 | ADDED | 49,400 | +3,500 | +7.6% | 0.00% | $297K | $6.02 |
| 2024 Q3 | REDUCED | 45,900 | -8,600 | -15.8% | 0.00% | $321K | $7.00 |
| 2024 Q2 | REDUCED | 54,500 | -48,100 | -46.9% | 0.00% | $316K | $5.80 |
| 2024 Q1 | REDUCED | 102,600 | -531,569 | -83.8% | 0.00% | $734K | $7.15 |
| 2000 Q3 | UNCHANGED | 634,169 | — | 0% | 0.00% | $1.5M | — |
| 2000 Q2 | UNCHANGED | 634,169 | — | 0% | 0.00% | $1.5M | — |
As of 2025 Q4 — sorted by position size